Real-World Data Validation of NAPOLI-1 Nomogram for the Prediction of Overall Survival in Metastatic Pancreatic Cancer.

Yung-Yeh SuNai-Jung ChiangYi-Hsin Connie YangChia-Jui YenLi-Yuan BaiChang-Fang ChiuShih-Chang ChuangShih-Hung YangWen-Chi Chou Jen-Shi Chen Tai-Jan ChiuYen-Yang ChenDe-Chuan ChanCheng-Ming PengSz-Chi ChiuChung-Pin Li Yan-Shen ShanLi-Tzong Chen

Published in: Cancers (2023)

Our results support the usefulness of the NAPOLI-1 nomogram for risk stratification in gemcitabine-refractory metastatic PDAC treated with nal-IRI+5-FU/LV in daily practice. We further showed that the RDI at 6 weeks is an independent prognostic factor beyond the NAPOLI-1 nomogram.

Keyphrases

prognostic factors
lymph node metastasis
squamous cell carcinoma
small cell lung cancer
healthcare
primary care
physical activity
electronic health record
locally advanced
big data
gestational age
rectal cancer